Ocular sarcoidosis

S Pasadhika, JT Rosenbaum - Clinics in chest medicine, 2015 - pmc.ncbi.nlm.nih.gov
Sarcoidosis is one of the leading causes of inflammatory eye disease. Ocular sarcoidosis
can involve any part of the eye and its adnexal tissues, and may cause uveitis …

Oxidative stress and reactive oxygen species: a review of their role in ocular disease

L Ung, U Pattamatta, N Carnt… - Clinical …, 2017 - portlandpress.com
For many years, oxidative stress arising from the ubiquitous production of reactive oxygen
species (ROS) has been implicated in the pathogenesis of various eye diseases. While …

Expert panel recommendations for the use of anti–tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

G Levy-Clarke, DA Jabs, RW Read, JT Rosenbaum… - Ophthalmology, 2014 - Elsevier
Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …

Current concepts in the etiology and treatment of Behçet disease

C Evereklioglu - Survey of ophthalmology, 2005 - Elsevier
Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …

Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations

PP Sfikakis, N Markomichelakis, E Alpsoy… - …, 2007 - academic.oup.com
Behcet's disease (BD) is a multisystem, chronic-relapsing, inflammatory disorder classified
among the vasculitides [1, 2]. It has a worldwide distribution being more prevalent in the …

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis

S Pasadhika, JT Rosenbaum - Biologics: Targets and Therapy, 2014 - Taylor & Francis
Uveitis is one of the leading causes of blindness worldwide. Noninfectious uveitis may be
associated with other systemic conditions, such as human leukocyte antigen B27-related …

Update on the therapy of Behçet disease

Z Saleh, T Arayssi - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation

A Galor, VL Perez, JP Hammel, CY Lowder - Ophthalmology, 2006 - Elsevier
PURPOSE: Anti–tumor necrosis factor α (anti–TNF-α) agents are being used increasingly in
refractory inflammatory eye diseases. We reviewed our patients on etanercept and infliximab …